Medical Affairs function at bio-pharmaceutical companies plays a vital role in bridging the gap between commercial and R&D operations. Evidently, across the global healthcare landscape, the Medical Affairs function is essential to meeting current challenges in clinical development, market education, and regulatory compliance.
In India, the Medical Affairs function is still developing, following a similar path to maturity as that traveled by MA groups in Mature Markets. Medical Affairs groups in India need to establish a clear value proposition in order to evolve beyond their traditional roles.
Best Practices, LLC's recent case study illustrates how mature and Indian biopharmaceutical companies include Abbott, Alkem Laboratories, AstraZeneca, Biocon, MSD Pharma, Ranbaxy, Sanofi & Astellas Pharma are structuring and managing their Medical Affairs organizations today. The study also examines recent trends in budget and staffing resources, key challenges and top success factors for the function particularly for Indian organizations.
Coimbatore Call Girls in Coimbatore 7427069034 genuine Escort Service Girl 10...
India and Medical Affairs: Building Best-in-Class Medical Affairs Capabilities In India – A Case Study For High-Growth Emerging Markets
1. BEST PRACTICES,
®
LLC
Best Practices, LLC Strategic Benchmarking Research
Building Best-in-Class Medical Affairs
Capabilities In India – A Case Study
For High-Growth Emerging Markets